Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOutset Medical EVP of R&D, Operations and Service Marc Nash to depart June 5
Filed May 29, 2026 · Period ending May 26, 2026 · ~1 min read
Key Changes
-
medium
Marc Nash, Executive Vice President overseeing R&D, Operations and Service, is leaving effective June 5, 2026 to pursue other professional opportunities. No dispute or disagreement with management cited.
Item 5.02 verify on EDGAR →
Summary
Outset Medical disclosed that Marc Nash, its Executive Vice President of R&D, Operations and Service, will depart on June 5, 2026. The company stated Nash is leaving to pursue other professional opportunities and emphasized the departure is not due to any disagreement with management or the board.
For retail investors, this represents a leadership change in critical operational areas including research and development, manufacturing operations, and service delivery. Nash's role spans functions central to product innovation and execution. The company has not yet announced a replacement or transition plan.
Watch for the company's next earnings call or investor update for details on succession planning and whether Nash's responsibilities will be redistributed among existing executives or filled externally. Any disruption to product development timelines or operational metrics in coming quarters could signal transition challenges.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify